Supplementary Data1 from A Randomized Phase II Study of Combination Atezolizumab and Varlilumab (CDX-1127) with or without Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer
Authors:
- Thatcher Ross HeumannThatcher Ross Heumann
- Jiayun LuJLJiayun Lu
- Hao WangHao Wang
- Mitch PhelpsMitch Phelps
- Qingfeng ZhuQingfeng Zhu
- Robert AndersRobert Anders
- Sarah MitchellSMSarah Mitchell
- James LeathermanJames Leatherman
- Nicole AbbottNANicole Abbott
- Kyeongmin KimKyeongmin Kim
- Teresa ImhofTITeresa Imhof
- Zhiliang XieZXZhiliang Xie
Open Access
- 15 September 2026
- other
- Published by American Association for Cancer Research (AACR)